BRAF and neoplasm: BRAF-mutant melanoma may achieve immune escape through several mechanisms, including preventing antigen-presenting cells from presenting tumor antigens and subsequently activating T cells, resulting in the low expression of human leucocyte antigen (HLA) class I molecules and melanoma differentiation antigens, and promoting the accumulation of myeloid-derived suppressor cells and regulatory T cells (47–49).